LUPIN
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Lupin along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.88₹ 16.95
As on Sep 29, 2025, 4:01 PM IST
Lupin Price Performance
Today's LowToday's High
₹1,920.15₹1,957.50
₹1,937.70
52 Weeks' Low52 Weeks' High
₹1,774.00₹2,403.45
₹1,937.70
Open Price
₹1,922.65
Prev. Close
₹1,920.75
Volume
10,900
Over the last 5 years, the share price of Lupin has gained 13.97% CAGR. Over the past year, the corresponding return has been -12.78%.
Lupin’s current P/E of 23.92x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Lupin Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lupin | -3.39 | 2.06 | -0.01 | -0.96 | -11.53 | 43.47 | 13.97 |
| Sun Pharmaceutical Industries | -2.47 | 1.76 | -5.13 | -6.26 | -17.42 | 21.05 | 25.54 |
| Divi's Laboratories | -5.39 | -6.01 | -15.95 | 3.18 | 5.12 | 15.89 | 13.11 |
| Torrent Pharmaceuticals | -1.71 | 0.25 | 5.31 | 12.86 | 5.61 | 32.79 | 21.67 |
| Cipla | -2.58 | -6.24 | -1.11 | 3.05 | -10.00 | 10.58 | 13.95 |
| Dr. Reddy's Laboratories | -5.57 | -3.52 | -3.78 | 7.19 | -8.61 | 13.88 | 3.79 |
| Mankind Pharma | -3.76 | -2.09 | 6.18 | 0.39 | -2.19 | 20.09 | 11.61 |
| Zydus Lifesciences | -5.08 | 0.16 | 0.27 | 13.08 | -7.12 | 40.14 | 20.50 |
| Alkem Laboratories | -2.59 | 2.03 | 9.52 | 11.86 | -10.79 | 17.92 | 14.30 |
| Aurobindo Pharma | -2.13 | 5.93 | -4.29 | -4.27 | -25.63 | 29.27 | 6.27 |
| Abbott India | -2.07 | -7.63 | -16.87 | -2.25 | 1.60 | 17.84 | 12.66 |
| Glenmark Pharmaceuticals | -2.95 | 1.59 | 11.74 | 29.83 | 17.04 | 73.55 | 31.65 |
| GlaxoSmithKline Pharmaceuticals | -0.39 | -1.98 | -18.83 | -1.59 | -0.21 | 25.66 | 11.76 |
| Biocon | -5.31 | -3.45 | -4.27 | 0.37 | -6.24 | 6.71 | -5.45 |
| Laurus Labs | -7.47 | -2.12 | 16.15 | 40.72 | 81.96 | 18.34 | 23.59 |
| Anthem Biosciences | -6.68 | -5.97 | 4.91 | 4.91 | 4.91 | 1.61 | 0.96 |
| Ipca Laboratories | -5.40 | -3.43 | -4.99 | -5.33 | -11.87 | 13.39 | 4.90 |
| Cohance Lifesciences | -2.80 | -3.16 | -9.62 | -18.69 | -25.54 | 27.11 | 16.88 |
| Gland Pharma | -1.36 | 6.50 | 8.64 | 27.99 | 10.87 | -1.12 | 1.80 |
| Ajanta Pharma | -4.05 | -0.50 | -5.20 | -6.73 | -23.73 | 24.75 | 18.19 |
Over the last one year, Lupin has declined 11.53% compared to peers like Sun Pharmaceutical Industries (-17.42%), Divi's Laboratories (5.12%), Torrent Pharmaceuticals (5.61%). From a 5 year perspective, Lupin has outperformed peers relative to Sun Pharmaceutical Industries (25.54%) and Divi's Laboratories (13.11%).
Lupin Financials
Lupin Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,028.9 | 1,969.99 |
| 10 | 2,025.16 | 1,986.64 |
| 20 | 1,975.01 | 1,983.57 |
| 50 | 1,952.69 | 1,968.65 |
| 100 | 1,967.17 | 1,974.26 |
| 200 | 2,024.78 | 1,974 |
Lupin Share Holding Pattern
In the latest quarter, Lupin saw a drop in promoter holding to 46.91%, while DII stake increased to 25.55%, FII holding fell to 21.25%, and public shareholding moved up to 6.28% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Lupin Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Balanced Advantage Fund - Regular Plan | 56,30,582 | 1.06 | 1,066.94 |
| HDFC Top 100 Fund - Regular Plan | 46,15,980 | 2.32 | 874.68 |
| HDFC Flexi Cap Fund - Regular Plan | 42,00,000 | 0.97 | 795.86 |
| Mirae Asset Large & Midcap Fund | 32,02,378 | 1.52 | 606.82 |
| ICICI Prudential Value Discovery Fund | 28,23,402 | 1 | 535.01 |
| SBI Long Term Equity Fund | 26,87,887 | 1.7 | 509.33 |
| Nippon India Pharma Fund | 26,83,991 | 6.09 | 508.59 |
| Mirae Asset Midcap Fund | 26,66,121 | 3.01 | 505.2 |
| Nippon India Growth Fund | 25,52,382 | 1.26 | 483.65 |
| Nippon India Multi Cap Fund | 25,20,027 | 1.03 | 477.52 |
Lupin Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Lupin Options
Lupin Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 29, 2025, 12:20 PM IST | Lupin Ltd. - Announcement under Regulation 30 (LODR)-Acquisition |
| Sep 26, 2025, 2:28 AM IST | Lupin Ltd. - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Sep 26, 2025, 2:24 AM IST | Lupin Ltd. - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Sep 24, 2025, 10:15 PM IST | Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 23, 2025, 4:44 PM IST | Lupin Ltd. - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
About Lupin
Lupin Ltd. is a Public Limited Listed company incorporated on 01/03/1983 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH1983PLC029442 and registration number is 029442. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 16967.50 Cr. and Equity Capital is Rs. 91.32 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressKalpataru Inspire, 3rd Floor, Mumbai Maharashtra 400055
- Contact
Management
- Mrs. Manju D GuptaChairperson
- Mr. Nilesh D GuptaManaging Director
- Ms. Vinita GuptaDirector & CEO
- Mr. Ramesh SwaminathanExecutive Director & Global CFO
- Mr. Mark D McDadeIndependent Director
- Dr. Punita Kumar-SinhaIndependent Director
- Mr. Jean-Luc BelingardIndependent Director
- Mr. Jeffrey KindlerIndependent Director
- Mr. Alfonso ZuluetaIndependent Director
- Mr. K B S AnandIndependent Director
- Mr. Punita LalIndependent Director
FAQs on Lupin Share Price
What is the share price of Lupin?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lupin is ₹1,937.70 as on Sep 29, 2025.
What kind of stock is Lupin?
The Lupin is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Lupin?
The market cap of Lupin is ₹88,505.97 Cr as on Sep 29, 2025.
What are today's High and Low prices of Lupin?
Today’s highest and lowest price of Lupin are ₹1,957.50 and ₹1,920.15.
What are the 52 Week High and 52 Week Low of Lupin?
The 52-week high/low is the highest and lowest price at which Lupin stock has traded in the past 52-week or nearly a year. The 52-week high of Lupin is ₹2,403.45 and 52-week low of Lupin is ₹1,774.00 as on Sep 29, 2025.
How has the Lupin performed historically in terms of returns?
The Lupin has shown returns of 0.88% over the past day, 1.85% for the past month, 0.04% over 3 months, -12.78% over 1 year, 43.47% across 3 years, and 13.97% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Lupin?
P/E ratio of and PB ratio of Lupin are 23.92 and 5.66 on Sep 29, 2025. While the company gives a dividend yield of 0.62 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data